Systemic atopy and upper-airway disease define susceptibility to incident asthma after COVID-19 in Korea
Open Access
- 27 June 2026
- journal article
- research article
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Abstract
Incident asthma is an important respiratory sequela after COVID-19, but it is unclear which allergic phenotypes amplify risk. Using a linked nationwide Korean database of 3,987,182 individuals with confirmed severe acute respiratory syndrome coronavirus 2 infection, we compare claims-based incident asthma in those with pre-existing systemic atopy and/or upper-airway disease (allergic rhinitis, chronic rhinosinusitis, atopic dermatitis or food allergy) versus those without after 1:1 propensity score matching. During follow-up to 31 December 2022, participants with pre-existing disease have higher asthma incidence than matched controls (3.55 vs 2.13 per 1,000 person-years), with a hazard ratio of 1.66 (95% confidence interval 1.58–1.75). Asthma risk is elevated for each condition and increases with greater disease burden. These findings show that pre-existing allergic and upper-airway phenotypes stratify post-COVID incident asthma risk on a national scale, supporting targeted surveillance in high-risk subgroups.Keywords
Funding Information
- Korea Health Industry Development Institute (RS-2024-00410184)
- Ministry of Food and Drug Safety (22183MFDS431)
This publication has 30 references indexed in Scilit:
- Global, regional, and national burden of asthma and atopic dermatitis, 1990–2021, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021The Lancet Respiratory Medicine, 2025
- IL-33 is associated with alveolar dysfunction in patients with viral lower respiratory tract diseaseMucosal Immunology, 2024
- Long-term risks of respiratory diseases in patients infected with SARS-CoV-2: a longitudinal, population-based cohort studyeClinicalMedicine, 2024
- Increased Risk of New-Onset Asthma After COVID-19: A Nationwide Population-Based Cohort StudyThe Journal of Allergy and Clinical Immunology: In Practice, 2023
- Epidemiology of patients with asthma in Korea: Analysis of the NHISS database 2006–2015World Allergy Organization Journal, 2023
- Chronic cough and cough hypersensitivity: from mechanistic insights to novel antitussivesThe Lancet Respiratory Medicine, 2022
- Immunosuppressive Drugs2022
- TH17 cells and corticosteroid insensitivity in severe asthmaJournal of Allergy and Clinical Immunology, 2021
- The atopic marchAnnals of Allergy, Asthma & Immunology, 2018
- Staphylococcus aureus colonization and IgE antibody formation to enterotoxins is increased in nasal polyposisJournal of Allergy and Clinical Immunology, 2004